4 employees
PolyMedix develops small molecule compounds for the treatment of acute cardiovascular disorders and infectious diseases.
2002
$14M
from 1 investors over 1 rounds
PolyMedix, Inc. raised $14M on April 1, 2010
Investors: Hercules Capital, Inc.